Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000176 | nuclear exosome (RNase complex) | 3 | 1 |
GO:0000177 | cytoplasmic exosome (RNase complex) | 5 | 1 |
GO:0000178 | exosome (RNase complex) | 4 | 1 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1905354 | exoribonuclease complex | 3 | 1 |
Related structures:
AlphaFold database: E9AUS5
Term | Name | Level | Count |
---|---|---|---|
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 8 | 1 |
GO:0000459 | exonucleolytic trimming involved in rRNA processing | 8 | 1 |
GO:0000460 | maturation of 5.8S rRNA | 9 | 1 |
GO:0000467 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9 | 1 |
GO:0000469 | cleavage involved in rRNA processing | 7 | 1 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006401 | RNA catabolic process | 5 | 1 |
GO:0006402 | mRNA catabolic process | 6 | 1 |
GO:0006417 | regulation of translation | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009890 | negative regulation of biosynthetic process | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009896 | positive regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010629 | negative regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0016073 | snRNA metabolic process | 7 | 1 |
GO:0016075 | rRNA catabolic process | 7 | 1 |
GO:0016078 | tRNA catabolic process | 7 | 1 |
GO:0016180 | snRNA processing | 8 | 1 |
GO:0017148 | negative regulation of translation | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0019439 | aromatic compound catabolic process | 4 | 1 |
GO:0031123 | RNA 3'-end processing | 7 | 1 |
GO:0031125 | rRNA 3'-end processing | 9 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031331 | positive regulation of cellular catabolic process | 6 | 1 |
GO:0034248 | regulation of amide metabolic process | 5 | 1 |
GO:0034249 | negative regulation of amide metabolic process | 6 | 1 |
GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' | 9 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034472 | snRNA 3'-end processing | 8 | 1 |
GO:0034473 | U1 snRNA 3'-end processing | 9 | 1 |
GO:0034475 | U4 snRNA 3'-end processing | 9 | 1 |
GO:0034476 | U5 snRNA 3'-end processing | 9 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0034661 | ncRNA catabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043628 | regulatory ncRNA 3'-end processing | 8 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 6 | 1 |
GO:0043634 | polyadenylation-dependent ncRNA catabolic process | 7 | 1 |
GO:0043928 | exonucleolytic catabolism of deadenylated mRNA | 9 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 1 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0046700 | heterocycle catabolic process | 4 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050779 | RNA destabilization | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051246 | regulation of protein metabolic process | 5 | 1 |
GO:0051248 | negative regulation of protein metabolic process | 6 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051254 | positive regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0061014 | positive regulation of mRNA catabolic process | 7 | 1 |
GO:0061157 | mRNA destabilization | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071025 | RNA surveillance | 6 | 1 |
GO:0071027 | nuclear RNA surveillance | 7 | 1 |
GO:0071028 | nuclear mRNA surveillance | 8 | 1 |
GO:0071029 | nuclear ncRNA surveillance | 7 | 1 |
GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 8 | 1 |
GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process | 8 | 1 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 7 | 1 |
GO:0071046 | nuclear polyadenylation-dependent ncRNA catabolic process | 8 | 1 |
GO:0071047 | polyadenylation-dependent mRNA catabolic process | 6 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 7 | 1 |
GO:0106354 | tRNA surveillance | 7 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903313 | positive regulation of mRNA metabolic process | 7 | 1 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 1 |
GO:2000113 | obsolete negative regulation of cellular macromolecule biosynthetic process | 7 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.323 |
CLV_C14_Caspase3-7 | 358 | 362 | PF00656 | 0.658 |
CLV_C14_Caspase3-7 | 81 | 85 | PF00656 | 0.536 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 284 | 286 | PF00675 | 0.502 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.443 |
CLV_NRD_NRD_1 | 344 | 346 | PF00675 | 0.448 |
CLV_PCSK_FUR_1 | 135 | 139 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.529 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.439 |
CLV_PCSK_KEX2_1 | 344 | 346 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 181 | 185 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.388 |
DEG_APCC_DBOX_1 | 137 | 145 | PF00400 | 0.441 |
DEG_SPOP_SBC_1 | 185 | 189 | PF00917 | 0.698 |
DOC_CYCLIN_RxL_1 | 251 | 263 | PF00134 | 0.411 |
DOC_MAPK_DCC_7 | 255 | 264 | PF00069 | 0.336 |
DOC_MAPK_gen_1 | 107 | 114 | PF00069 | 0.448 |
DOC_MAPK_gen_1 | 135 | 143 | PF00069 | 0.381 |
DOC_MAPK_gen_1 | 255 | 264 | PF00069 | 0.351 |
DOC_MAPK_gen_1 | 34 | 41 | PF00069 | 0.371 |
DOC_MAPK_MEF2A_6 | 107 | 114 | PF00069 | 0.428 |
DOC_MAPK_MEF2A_6 | 255 | 264 | PF00069 | 0.336 |
DOC_MAPK_MEF2A_6 | 34 | 41 | PF00069 | 0.298 |
DOC_PP1_RVXF_1 | 284 | 291 | PF00149 | 0.391 |
DOC_PP2B_LxvP_1 | 257 | 260 | PF13499 | 0.428 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.341 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.714 |
DOC_USP7_MATH_1 | 202 | 206 | PF00917 | 0.544 |
DOC_USP7_MATH_1 | 272 | 276 | PF00917 | 0.616 |
DOC_USP7_MATH_1 | 354 | 358 | PF00917 | 0.531 |
DOC_USP7_MATH_1 | 56 | 60 | PF00917 | 0.679 |
DOC_USP7_MATH_1 | 78 | 82 | PF00917 | 0.369 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.584 |
DOC_USP7_UBL2_3 | 282 | 286 | PF12436 | 0.349 |
DOC_WW_Pin1_4 | 187 | 192 | PF00397 | 0.576 |
DOC_WW_Pin1_4 | 299 | 304 | PF00397 | 0.328 |
DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.579 |
DOC_WW_Pin1_4 | 76 | 81 | PF00397 | 0.401 |
LIG_14-3-3_CanoR_1 | 285 | 291 | PF00244 | 0.431 |
LIG_APCC_ABBA_1 | 226 | 231 | PF00400 | 0.452 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.679 |
LIG_BIR_III_2 | 115 | 119 | PF00653 | 0.379 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.513 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.359 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.358 |
LIG_FHA_2 | 310 | 316 | PF00498 | 0.334 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.607 |
LIG_LIR_Apic_2 | 315 | 320 | PF02991 | 0.481 |
LIG_LIR_Apic_2 | 365 | 369 | PF02991 | 0.502 |
LIG_LIR_Gen_1 | 139 | 148 | PF02991 | 0.465 |
LIG_LIR_Gen_1 | 289 | 298 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 376 | 386 | PF02991 | 0.470 |
LIG_LIR_Gen_1 | 63 | 69 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.488 |
LIG_LIR_Nem_3 | 376 | 382 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 63 | 67 | PF02991 | 0.481 |
LIG_NRBOX | 295 | 301 | PF00104 | 0.316 |
LIG_PCNA_yPIPBox_3 | 285 | 299 | PF02747 | 0.395 |
LIG_PDZ_Class_3 | 401 | 406 | PF00595 | 0.478 |
LIG_SH2_CRK | 338 | 342 | PF00017 | 0.405 |
LIG_SH2_PTP2 | 366 | 369 | PF00017 | 0.537 |
LIG_SH2_PTP2 | 64 | 67 | PF00017 | 0.480 |
LIG_SH2_SRC | 64 | 67 | PF00017 | 0.480 |
LIG_SH2_STAP1 | 124 | 128 | PF00017 | 0.381 |
LIG_SH2_STAP1 | 248 | 252 | PF00017 | 0.408 |
LIG_SH2_STAT3 | 349 | 352 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 335 | 338 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 366 | 369 | PF00017 | 0.537 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.480 |
LIG_SH3_1 | 42 | 48 | PF00018 | 0.468 |
LIG_SH3_3 | 305 | 311 | PF00018 | 0.373 |
LIG_SH3_3 | 364 | 370 | PF00018 | 0.629 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.468 |
LIG_SH3_4 | 282 | 289 | PF00018 | 0.397 |
LIG_SUMO_SIM_par_1 | 297 | 302 | PF11976 | 0.346 |
MOD_CK1_1 | 186 | 192 | PF00069 | 0.712 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.578 |
MOD_CK1_1 | 357 | 363 | PF00069 | 0.541 |
MOD_CK1_1 | 371 | 377 | PF00069 | 0.573 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.667 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.696 |
MOD_CK2_1 | 309 | 315 | PF00069 | 0.330 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.452 |
MOD_CK2_1 | 60 | 66 | PF00069 | 0.428 |
MOD_CK2_1 | 94 | 100 | PF00069 | 0.665 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.495 |
MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.730 |
MOD_GlcNHglycan | 204 | 207 | PF01048 | 0.593 |
MOD_GlcNHglycan | 237 | 240 | PF01048 | 0.520 |
MOD_GlcNHglycan | 357 | 360 | PF01048 | 0.628 |
MOD_GlcNHglycan | 370 | 373 | PF01048 | 0.520 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.567 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.672 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.680 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.531 |
MOD_GSK3_1 | 350 | 357 | PF00069 | 0.604 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.496 |
MOD_GSK3_1 | 373 | 380 | PF00069 | 0.340 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.496 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.626 |
MOD_N-GLC_1 | 131 | 136 | PF02516 | 0.404 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.504 |
MOD_N-GLC_1 | 67 | 72 | PF02516 | 0.493 |
MOD_N-GLC_1 | 91 | 96 | PF02516 | 0.784 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.300 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.545 |
MOD_NEK2_1 | 235 | 240 | PF00069 | 0.518 |
MOD_NEK2_2 | 260 | 265 | PF00069 | 0.359 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.668 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.355 |
MOD_Plk_2-3 | 12 | 18 | PF00069 | 0.355 |
MOD_Plk_4 | 362 | 368 | PF00069 | 0.597 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.422 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.313 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.373 |
MOD_ProDKin_1 | 187 | 193 | PF00069 | 0.577 |
MOD_ProDKin_1 | 299 | 305 | PF00069 | 0.336 |
MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.584 |
MOD_ProDKin_1 | 76 | 82 | PF00069 | 0.403 |
TRG_DiLeu_BaEn_2 | 221 | 227 | PF01217 | 0.441 |
TRG_DiLeu_BaLyEn_6 | 291 | 296 | PF01217 | 0.456 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.425 |
TRG_ENDOCYTIC_2 | 338 | 341 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 136 | 138 | PF00400 | 0.440 |
TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.403 |
TRG_Pf-PMV_PEXEL_1 | 29 | 33 | PF00026 | 0.388 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PD98 | Leptomonas seymouri | 68% | 96% |
A0A0S4JA55 | Bodo saltans | 29% | 100% |
A0A1X0NWT9 | Trypanosomatidae | 45% | 100% |
A0A3R7M9T9 | Trypanosoma rangeli | 49% | 100% |
A0A3S7WW44 | Leishmania donovani | 92% | 100% |
A4HYX8 | Leishmania infantum | 93% | 100% |
C9ZII6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AIJ0 | Leishmania braziliensis | 83% | 100% |
Q4QCR0 | Leishmania major | 92% | 100% |
V5D565 | Trypanosoma cruzi | 46% | 100% |